Parameters group studied (n = 10) | BUN (mg/dl) | Creatinine (mg/dl) | Serum glucose (mg/dl) | |
Normal control gp. | 24.1bcd ± 1.7 | 0.32bcd ± 0.067 | 98.1bd ± 11.29 | |
Diabetic gp. | 30.3acde ± 1.7 | 0.64acde ± 0.084 | 474.6acde ± 16.94 | |
Ischemic reperfused (IR) gp. | 34.8abde ± 2.2 | 1.21abde ± 0.035 | 103.6bd ± 2.30 | |
Diabetic+ I/R gp. | 48.9abce ± 6.0 | 2.56abce ± 0.13 | 495abce ± 22.16 | |
Sitaglipten treated (Diabetic+I/R) gp. | 25.5bcd ± 1.4 | 0.33bcd ± 0.24 | 100bd ± 12.29 | |
F (p) | 102.513* (<0.001) | 503.879* (<0.001) | 2088.216* (<0.001) | |
LSD (5%) | 2.788 | 0.117 | 13.034 |